Page last updated: 2024-10-21

2-amino-5-phosphonovalerate and Blood Pressure, Low

2-amino-5-phosphonovalerate has been researched along with Blood Pressure, Low in 3 studies

2-Amino-5-phosphonovalerate: The D-enantiomer is a potent and specific antagonist of NMDA glutamate receptors (RECEPTORS, N-METHYL-D-ASPARTATE). The L form is inactive at NMDA receptors but may affect the AP4 (2-amino-4-phosphonobutyrate; APB) excitatory amino acid receptors.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hashim, MA1
Tadepalli, AS1
Canesin, RO1
Bonagamba, LG1
Machado, BH1
Hong, LZ1
Cheng, PW1
Cheng, WH1
Chen, SR1
Wang, LL1
Tseng, CJ1

Other Studies

3 other studies available for 2-amino-5-phosphonovalerate and Blood Pressure, Low

ArticleYear
Hypotension to central endothelin-1: effect of glutamate receptor blockade.
    Biochemical and biophysical research communications, 1994, Nov-30, Volume: 205, Issue:1

    Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Dizocilpine Maleate; End

1994
Bradycardic and hypotensive responses to microinjection of L-glutamate into the lateral aspect of the commissural NTS are blocked by an NMDA receptor antagonist.
    Brain research, 2000, Jan-03, Volume: 852, Issue:1

    Topics: 2-Amino-5-phosphonovalerate; Animals; Blood Pressure; Bradycardia; Excitatory Amino Acid Antagonists

2000
Involvement of NMDA receptors in nicotine-mediated central control of hypotensive effects.
    The Chinese journal of physiology, 2012, Oct-31, Volume: 55, Issue:5

    Topics: Animals; Blood Pressure; Bradycardia; Dizocilpine Maleate; Drug Interactions; Excitatory Amino Acid

2012